Kazakhstan Parliament Addresses Public Concerns Over Healthcare Funding

Kazakhstan Parliament Member Explains MAMS Law Amendments Nur-Sultan, Kazakhstan – May 21, 2025 – A recent amendment to Kazakhstan's Medical and Pharmaceutical Services (MAMS) law has sparked public interest, prompting a statement from Majilis deputy Ashat Aimangambetov. Aimangambetov addressed concerns about the allocation of significant funds, emphasizing the government's commitment to transparency. "One of the key improvements is transparency," Aimangambetov stated in a recent interview. "We want to ensure that citizens can see exactly where the trillions of tenge are going." He highlighted the public's right to know how funds are used and the government's efforts to increase accountability. The amendments aim to improve public access to information on government spending, fostering greater trust and accountability. This initiative is part of a broader effort to strengthen transparency and fight corruption within the healthcare sector. The changes are expected to improve the efficiency and effectiveness of the MAMS system, ultimately benefiting the citizens of Kazakhstan.